Insider trades

Peter Salzmann, CEO of Immunovant IMVT, has filed 0 purchases and 32 sales on the open market. The latest trade was on 25/04/16.

Peter Salzmann

CEO
First filing
23/01/13
Trades
41 trades
Buys / sales
0 / 32
12-month net buying
No record
Last trade
25/04/16

Trading activity

Transactions

Trade type
Open-market sale25/04/1625/04/178,321 sh$14.89$123,899.69−0.7%
Open-market sale25/04/0925/04/1128,094 sh$12.99$364,941.06−2.3%
Open-market sale25/02/1925/02/2115,439 sh$20.86$322,057.54−1.6%
IMVT
Open-market sale25/01/1525/01/178,767 sh2 trades$23.83avg.$208,899.97−0.9%
Open-market sale25/01/0825/01/105,105 sh$24.10$123,030.5−0.5%
Open-market sale24/11/2024/11/2216,692 sh$25.45$424,811.4−1.7%
Open-market sale24/10/1624/10/189,095 sh$28.79$261,845.05−0.9%
Open-market sale24/10/0924/10/114,460 sh$29.56$131,837.6−0.4%
IMVT
Open-market sale24/08/2124/08/2315,068 sh2 trades$31.86avg.$480,052.16−1.5%
IMVT
Open-market sale24/07/1724/07/198,685 sh2 trades$29.69avg.$257,887.5−0.8%
Open-market sale24/07/0924/07/104,619 sh$28.06$129,609.14−0.4%
Open-market sale24/05/2224/05/2416,163 sh$29.65$479,232.95−1.5%
IMVT
Open-market sale24/04/1724/04/1934,079 sh2 trades$29.06avg.$990,269.16−3.1%
Open-market sale24/04/0924/04/104,807 sh$31.18$149,882.26−0.4%
Open-market sale24/02/2224/02/2313,454 sh$36.15$486,362.1−1.4%
Open-market sale24/01/0524/01/093,824 sh$38.59$147,568.16−0.4%
IMVT
Open-market sale23/11/2223/11/2416,217 sh2 trades$32.78avg.$531,581.07−1.7%
IMVT
Open-market sale23/10/0523/10/065,239 sh2 trades$36.24avg.$189,887.31−0.5%
IMVT
Open-market sale23/08/3023/09/0156,774 sh2 trades$22.02avg.$1,250,337.86−5.5%
IMVT
Open-market sale23/08/1423/08/16103,058 sh2 trades$21.42avg.$2,207,177.52−9.1%